Submitted by Anonymous (not verified) on 15 September 2023 - 11:00 Summary of opinion: Takhzyro,lanadelumab, 14/09/2023, Positive Link: https://www.ema.europa.eu/en/medicines/human/summaries-opinion/takhzyroSource: What's new